Comparison of responses to acetylcholine and serotonin on isolated canine and human coronary arteries

Canine and human coronary arteries were studied in organ baths to compare the responses to acetylcholine and serotonin in the two species. The human coronary rings were isolated from seven patients without cardiac disease (mean age 15 years, range 7–20). In one set of experiments canine and human pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular research 1989-09, Vol.23 (9), p.780-787
Hauptverfasser: BERKENBOOM, GUY, UNGER, PHILIPPE, FANG, ZHEN YING, DEGRE, SERGE, FONTAINE, JEANINE
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Canine and human coronary arteries were studied in organ baths to compare the responses to acetylcholine and serotonin in the two species. The human coronary rings were isolated from seven patients without cardiac disease (mean age 15 years, range 7–20). In one set of experiments canine and human preparations were incubated with phentolamine, propranolol and ketanserin (all at 1 μmol·litre−1 concentration) and precontracted with prostaglandin F2α (PGF2α 1–2 μmol·litre−1). Acetylcholine (0.1–10 μmol·litre−1) and serotonin (0.1–100 μmol·litre−1) relaxed canine preparations dose dependently, the maximum responses (expressed as % of depression of PGF2α response) being 84 (SEM 6)% (n = 9) and 51(5)% (n = 6) respectively. In the same experimental conditions, acetylcholine and serotonin failed to relax the human coronary rings (n = 11) while substance P and bradykinin induced relaxations of 72(4)% (n = 11) and 66(7)% (n = 11) of PGF2α response respectively. In another set of experiments, dose-contraction curves were constructed for acetylcholine or serotonin (in presence of phentolamine and propranolol). On human rings with endothelium, methylene blue (10 μmol·litre−1), a non-specific inhibitor of endothelium derived relaxing factor (EDRF), potentiated these dose-contraction curves: markedly for serotonin, the EC50 decreasing from 1.2(0.2) to 0.22(0.08) μmol·litre−1 (n = 11, p
ISSN:0008-6363
1755-3245
DOI:10.1093/cvr/23.9.780